![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, September 12, 2017 11:32:34 AM
SESSION 7:
VACCINES/VACCINATION
Moderator: Jeffrey A. Hubbell
(University of Chicago, Chicago, Illinois, USA)
14.00-14.30
‘Soluble glycopolymer conjugates as nanovaccines’
Jeffrey A. Hubbell
(University of Chicago, Chicago, Illinois, USA)
14.30-15.00
‘Afluria quadrivalent influenza vaccine: A challenging history overcome’
Heather Davis
(Seqirus, Maidenhead, Berkshire, UK)
15.00-15.20
‘MACIVIVA: Manufacturing of cold-chain independent virosome-based vaccine’
Mario Amacker, Sylvain Fleury and Toon Stegmann
(Mymetics SA, Epalinges, Switzerland)
15.20-15.40
‘Novel antigen-carrier system for multi-epitope subunit vaccine candidate against tuberculosis’
Kata Horvati1, Gergö Gyulai2, Éva Kiss2, Bernadett Pályi3, Zoltán Kis3, Sándor Dávid4, Nóra Szabó4, Kinga Fodor5 and Szilvia Bösze1
(1 MTA-ELTE Research Group of Peptide Chemistry, Budapest, Hungary; 2 Laboratory of Interfaces and Nanostructures, Eötvös L. University, Budapest, Hungary; 3 National Biosafety Laboratory, National Center for Epidemiology, Budapest, Hungary; 4 Laboratory of Bacteriology, Korányi National Institute for Tuberculosis, Budapest, Hungary; 5 Department of Veterinary Forensics, Law and Economics, University of Veterinary Medicine, Budapest, Hungary)
15.40-16.00
Tea Break & Posters
http://www.meetingsmanagement.co.uk/index.php?option=com_content&view=article&id=434&Itemid=776
http://www.meetingsmanagement.co.uk/index.php?option=com_content&view=article&id=394&Itemid=766
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM